Skip to main navigation Skip to search Skip to main content

Author Correction: BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity (Experimental & Molecular Medicine, (2022), 54, 9, (1450-1460), 10.1038/s12276-022-00840-x)

  • Seung Hyun Bae
  • , Jung Hoon Kim
  • , Tae Hyun Park
  • , Kyeong Lee
  • , Byung Il Lee
  • , Hyonchol Jang
  • National Cancer Center Korea
  • Cornell University

Research output: Contribution to journalComment/debate

Abstract

Correction to: Experimental & Molecular Medicinehttps://doi.org/10.1038/s12276-022-00840-x, published online 02 September 2022 After online publication of this article, the authors noticed an error in the Fig. 5h section. During figure assembly, the image corresponding to the siAXL#1 condition in Fig. 5h was inadvertently replaced with the siScrambled image from Fig. 5e. (Figure presented.) The correct siAXL#1 image was obtained from the same experiment performed under identical conditions. Original data are available upon request. This error does not affect the quantitative analyses, statistical results, or the conclusions of the manuscript. The authors apologize for any inconvenience caused. The original article has been corrected.

Original languageEnglish
Pages (from-to)300
Number of pages1
JournalExperimental and Molecular Medicine
Volume58
Issue number1
DOIs
StatePublished - Feb 2026

Fingerprint

Dive into the research topics of 'Author Correction: BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity (Experimental & Molecular Medicine, (2022), 54, 9, (1450-1460), 10.1038/s12276-022-00840-x)'. Together they form a unique fingerprint.

Cite this